Fingerprint
Dive into the research topics of 'Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically